Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021

SELL
$4.08 - $7.83 $62,154 - $119,282
-15,234 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$6.78 - $9.04 $2,000 - $2,666
295 Added 1.97%
15,234 $120,000
Q1 2021

May 07, 2021

BUY
$8.18 - $23.98 $122,201 - $358,237
14,939 New
14,939 $126,000

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Altfest L J & CO Inc Portfolio

Follow Altfest L J & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Altfest L J & CO Inc with notifications on news.